The Fat Within: Why Atherosclerosis Is a Disease of Production, Not Consumption
For decades, the dominant narrative of cardiovascular disease pointed an accusatory finger at the dinner table. Fat consumed, fat deposited, arteries clogged. The logic seemed intuitive, the dietary guidelines followed, and the low-fat era reshaped what millions of people ate for a generation. Yet atherosclerosis continued. Heart attacks remained the leading cause of death in countries that had dramatically reduced dietary fat. Something in the story was incomplete.
The missing piece was hiding in plain sight, inside the body itself.
The human body is not a passive recipient of dietary fats. It is an active, continuous, and highly regulated producer of lipids. The liver synthesizes approximately one gram of cholesterol every day regardless of dietary intake. Triglycerides are assembled from glycerol and fatty acid chains, stored in adipose tissue, and mobilized as needed. Phospholipids are constructed constantly to maintain the integrity of every cell membrane in the body. Steroid hormones — estrogen, testosterone, cortisol — are derived from cholesterol synthesized internally. Eicosanoids, the signaling molecules that regulate inflammation and immune response, are produced from endogenous fatty acid chains. None of these processes depend on what was eaten for breakfast.
This endogenous lipid production is not a flaw. It is essential. The body produces fats because it needs them — for energy storage, for structural integrity at the cellular level, for hormonal signaling, for immune regulation. Under healthy conditions, these processes are exquisitely regulated. Insulin promotes fatty acid synthesis in the liver when energy is abundant. Glucagon and epinephrine shift the balance toward breakdown and mobilization when energy is needed. Negative feedback mechanisms adjust cholesterol synthesis in response to dietary intake — when more cholesterol arrives from food, the liver produces less. The system is designed for balance.
The question that atherosclerosis research has been slowly, and sometimes reluctantly, moving toward is this: what happens when that balance fails — not because of what enters the body from outside, but because of what the body does internally?
The answer, increasingly supported by genetic and metabolic evidence, is that the pathological driver of atherogenesis is not dietary fat but dysregulated endogenous fat production and elimination. When the mechanisms that govern lipid synthesis, modification, transport, and clearance are disturbed — whether through genetic predisposition, metabolic dysfunction, or both — the resulting lipid environment becomes atherogenic. The problem is not the fat on the plate. The problem is the fat the body makes when its regulatory systems have lost their balance.
This reframing has profound clinical implications. Familial hypercholesterolemia, one of the most powerful genetic risk factors for premature cardiovascular disease, is caused not by excessive dietary intake but by defective LDL receptor function — the machinery responsible for clearing endogenously produced cholesterol from the circulation. Elevated lipoprotein(a), another genetically determined risk factor, reflects a structural variant in endogenous lipoprotein synthesis that dietary modification can barely touch. The metabolic dysregulation driving small dense LDL production — the most atherogenic lipoprotein subtype — is rooted in hepatic triglyceride metabolism, itself driven more by carbohydrate excess and insulin resistance than by dietary fat consumption.
These findings do not vindicate unlimited dietary fat consumption, and they do not suggest that lifestyle is irrelevant. What they do is shift the center of gravity of the problem. The primary lesion in atherogenesis is internal, not external. It is a disturbance in the production, processing, or elimination of lipids that the body generates itself — a regulatory failure in a system that, when functioning well, maintains remarkable balance independent of what is eaten.
The old hypothesis — that dietary fat causes atherosclerosis — was never completely false. It captured a real relationship between lipid exposure and arterial disease. But it mistook a contributing variable for the fundamental cause. The fundamental cause lives deeper, in the genetics of lipid metabolism, in the hormonal and enzymatic regulation of endogenous synthesis, and in the conditions — insulin resistance, chronic inflammation, metabolic overload — that push an otherwise balanced system toward dysregulation.
Understanding this is not merely academic. It changes what questions physicians ask, what markers they measure, and what interventions they prioritize. The most important question is no longer what did this patient eat. It is how well is this patient's body managing the fats it makes itself.
You can learn more by reading our e-book or listening to our audiobook
Comments